RVL Pharmaceuticals, Inc. (NASDAQ: RVLP) is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. Our first FDA-approved product, Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% provides the foundation of our unwavering commitment to improve patients’ lives. Upneeq® is available through the UP+ Program which allows you to dispense Upneeq® directly to your appropriate adult patients. To learn more or to contact a representative for resources, please see information below:
Company/Brand Name: RVL Pharmaceuticals, Inc.
Company website: www.Upneeq.com
Company phone number: 866-600-4799
Company email address: CustomerCare@RVLPharma.com